The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Size Of The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market In 2026 And How Much Will It Reach By 2030?

The market for messenger ribonucleic acid (mrna) manufacturing services has experienced significant expansion recently. This market is projected to expand from $6.14 billion in 2025 to reach $7.12 billion by 2026, at a compound annual growth rate (CAGR) of 15.9%. Historically, this expansion can be ascribed to several factors, including the increasing research into mrna therapeutics, urgent demand for vaccine manufacturing, insufficient internal mrna production capabilities, the proliferation of CDMO collaborations, and the broadening of biotechnology pipelines.

The market for messenger ribonucleic acid (mrna) manufacturing services is anticipated to experience significant expansion in the coming years. This market is projected to reach $12.97 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.2%. Factors contributing to this projected growth include a rise in mRNA therapy trials, an expanding demand for contract manufacturing, advancements in personalized medicine, increased outsourcing by biotechnology companies, and the scaling up of commercial mRNA products. Key trends anticipated during the forecast period involve integrated mRNA process development services, large-scale in vitro transcription production, comprehensive LNP encapsulation services, swift technology transfer programs, and GMP-grade mRNA batch manufacturing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33216&type=smp

What Core Drivers Are Transforming The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

The increased clinical trial activity is anticipated to fuel the expansion of the messenger ribonucleic acid (mRNA) manufacturing service market moving forward. Clinical trial activity encompasses all processes involved in conducting and managing clinical studies to assess medical interventions in humans. This activity is on the rise due to the growing adoption of digital and decentralized trial models, which enable faster patient recruitment, remote monitoring, and more efficient data collection across broader populations. Messenger ribonucleic acid (mRNA) manufacturing services support clinical trial activity by ensuring the rapid and flexible production of mRNA-based therapies, facilitating timely supply for multiple trial phases and accelerating drug development. For instance, in December 2024, as reported by the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade association, the number of industry clinical trials initiated in the UK rose to 426 in 2023, from 411 in 2022. Thus, the escalating clinical trial activity is propelling the growth of the messenger ribonucleic acid (mRNA) manufacturing service market.

How Does Segment Analysis Break Down The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Structure?

The messenger ribonucleic acid (mrna) manufacturing service market covered in this report is segmented –

1) By Service Type: Process Development; Analytical Testing; Manufacturing; Fill-Finish; Other Service Types

2) By Scale of Operation: Research And Preclinical Scale; Clinical Scale; Commercial Scale

3) By Application: Vaccines; Therapeutics; Research; Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users

Subsegments:

1) By Process Development: Template Design And Optimization; In Vitro Transcription Process Design; Formulation Development; Process Scale-Up And Technology Transfer; Process Validation Support

2) By Analytical Testing: Identity And Purity Testing; Potency And Functional Assays; Impurity And Contaminant Analysis; Stability And Shelf Life Studies; Quality Control Release Testing

3) By Manufacturing: Plasmid Deoxyribonucleic Acid Production; In Vitro Transcription Manufacturing; Enzymatic Capping And Tailoring; Purification And Concentration; Large-Scale Batch Production

4) By Fill-Finish: Aseptic Filling Services; Vial And Syringe Filling; Lyophilization Services; Labeling And Packaging; Cold Chain Handling And Storage

5) By Other Service Types: Regulatory Support Services; Quality Assurance And Documentation; Supply Chain And Logistics Support; Technology Consulting Services; Custom Manufacturing Solutions

What Trends Are Influencing The Future Of The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

Major companies operating in the messenger ribonucleic acid (mRNA) manufacturing service market are increasingly focused on developing advanced solutions, such as in vitro transcription (IVT), to accelerate the production of high-quality, clinical-grade mRNA essential for vaccines and personalized therapies. In vitro transcription (IVT) refers to a laboratory method for synthesizing messenger RNA (mRNA) from a DNA template using RNA polymerase enzymes, enabling the creation of mRNA outside of living cells for research, therapeutic, or vaccine purposes. For example, in May 2025, GenScript Biotech Corporation, a China-based biotechnology company, introduced a GMP-like mRNA manufacturing service designed to support preclinical studies and IND-enabling research. This solution provides highly pure, scalable in vitro transcription (IVT) processes with strict control over critical quality attributes, including capping efficiency, poly(A) tail length, and impurity profiles. It facilitates a rapid transition from preclinical to clinical stages by ensuring consistent batch-to-batch production, offering flexible customization for various mRNA constructs, and reducing development timelines. Additionally, the GMP-like framework enhances regulatory readiness through improved traceability, standardized workflows, and comprehensive quality documentation, helping developers mitigate risks in later-stage manufacturing and accelerate overall clinical progress.

Which Organizations Are Operating Within The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

Major companies operating in the messenger ribonucleic acid (mrna) manufacturing service market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Biotechnologies, Evonik Industries AG, Lonza Group AG, Charles River Laboratories International Inc., Samsung Biologics Co. Ltd., WuXi Biologics Inc., Recipharm AB, Curia Global Inc., Emergent BioSolutions Inc., AGC Biologics Inc., Corden Pharma International GmbH, Rentschler Biopharma SE, GenScript ProBio, ST Pharm Co. Ltd., etherna Immunotherapies NV, BIOMAY AG., Porton Advanced Solutions Ltd., Wacker Biotech GmbH.

Access The Complete Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report:

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-manufacturing-service-market-report

Which Region Holds The Largest Share In The Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market?

North America was the largest region in the mRNA manufacturing service market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) manufacturing service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Messenger Ribonucleic Acid (MRNA) Manufacturing Service Market Report for Deeper Competitive Insights

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model